Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Weight loss jabs like Ozempic cuts risk of heart attack and stroke, study claims - Risk of serious conditions reduced ...
The weight loss jab has become a blockbuster pharmaceutical hit, with people, including the diabetics it was originally ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
“Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, ...
Study adds to evidence that semaglutide, also known by the brand names Ozempic or Wegovy, can be used for a range of chronic conditions ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...
Pharmaceutical giants highlight other benefits of weight-loss drugs from reducing heart attacks to tackling liver disease as ...